Insulet
PODD
#1886
Rank
A$15.73 B
Marketcap
A$227.20
Share price
5.35%
Change (1 day)
-51.55%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: A$15.73 Billion

As of June 2026 Insulet has a market cap of A$15.73 Billion. This makes Insulet the world's 1886th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$15.73 B-48.12%
2025A$30.33 B1.46%
2024A$29.89 B34.44%
2023A$22.23 B-25.98%
2022A$30.04 B18.7%
2021A$25.31 B15.48%
2020A$21.91 B42.99%
2019A$15.32 B130%
2018A$6.66 B29.59%
2017A$5.14 B71.32%
2016A$3.00 B1.55%
2015A$2.95 B-6.71%
2014A$3.16 B38.84%
2013A$2.28 B131.12%
2012A$0.98 B13.45%
2011A$0.87 B25.52%
2010A$0.69 B15.53%
2009A$0.60 B113.98%
2008A$0.28 B-59.26%
2007A$0.68 B

End of Day market cap according to different sources

On Jun 8th, 2026 the market cap of Insulet was reported to be:

A$14.93 Billion
by Nasdaq info icon info icon
A$14.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$812.12 B 5,060.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$226.25 B 1,337.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$149.82 B 852.06%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$1.453 T 9,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
A$1.71 B-89.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$5.05 B-67.90%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$42.94 B 172.91%๐Ÿ‡บ๐Ÿ‡ธ USA